Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Neurofilaments

Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease

Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer’s disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer’s disease.

Due to the similarity of the symptoms, differentiating patients with Alzheimer’s from those… Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease   



I have Alzheimer Disease

depression14 - hyperammonemia1 - developing alzheimer's disease1 - dementia of the alzheimer type1 - risk for cognitive decline1 - physical exercise1 - neuropsychological evaluations1 - dopamine-producing neurons4 - parkinson's risk2 - amyloid hypothesis1 - risk of parkinson's1 - olive oil1 - senile atrophy and aphasia1 - aripiprazole1 - progressive neurodegenerative disorder1 - latin dementia1 - pick’s disease1 - alzheimer's treatments3 - types of dementia2 - mediterranean and dash1 - ophthalmoplegia4 - mixed dementia1 - huntingtin1 - solanezumab1 - american psychiatric association3 - gastrointestinal disorders1 - iron lady1 - dementia patients care1 - brain disorder1 - retinopathy1 -